Paradigm Biopharmaceuticals | PAR - Ebitda

Stock Price
0.27
Daily Change
-0.01 -1.82%
Monthly
-16.92%
Yearly
-53.04%
Q1 Forecast
0.27

Paradigm Biopharmaceuticals reported AUD-5.86M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Avita Medical AUD -21.9M 12.04M Jun/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Pacific Edge NZD -13.97M 332K Sep/2024
PYC Therapeutics AUD -24.29M 1.3M Jun/2025
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025